Francis G. LeVeque - Concepedia

Concepedia

Author

Francis G. LeVeque

Harper University Hospital

Also Known As

F G LeVeque, F LEVEQUE, F. G. LeVeque, F. LeVeque, Francis G. LeVeque, Francis G. Leveque, Francis LeVeque, Francis Leveque

19

Publications

2.1K

Citations

11

H-Index

20

Concepts

All Affiliations

Harper University Hospital University of Washington UConn Health Wayne State University Fred Hutch Cancer Center

FG

About

Francis G. LeVeque is an author at Harper University Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	338
2	Health Sciences	2	2	233
3	Immunology	2	2	80
4	Pharmacology	2	2	164
5	Radiation Medicine	2	2	159

Francis G. LeVeque

×

11

Publications

2.1K

Citations

11

H-Index

	Year	Citations
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation Stephen T. Sonis, Gerry Oster, Hank Fuchs, Journal of Clinical Oncology	2001	680
Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy Stephen T. Sonis, June Eilers, Joel B. Epstein, Cancer	1999	398
A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. Francis G. LeVeque, Margaret A. Montgomery, D Potter, Journal of Clinical Oncology	1993	292
Benzydamine HCl for prophylaxis of radiation-induced oral mucositis Joel B. Epstein, Sol Silverman, Dario A. Paggiarino, Cancer	2001	268
Oral pilocarpine for radiation-induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials John W. Rieke, Mark D. Hafermann, Jonas T. Johnson, International Journal of Radiation OncologyBiologyPhysics OncologyRadiation TherapyMedicinePharmacotherapySafety Results	1995	139
Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. Charles W. Scarantino, Francis G. LeVeque, Ruth Swann, PubMed Radiation MedicineNeck Cancer PatientsRadiation TherapyMedicineOral Cavity	2006	94
The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: A double-blind placebo-controlled prospective Phase III study by Radiation Therapy Oncology Group 9901 Janice Ryu, S. Swann, Francis G. LeVeque, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineNeck Cancer PatientsRadiation TherapyMedicineImmunology	2007	65
Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors María Cecilia Foncuberta, P. J. Cagnoni, Christian Brandts, Journal of Immunotherapy	2001	52
Clinical evaluation of MGI 209, an anesthetic, film-forming agent for relief from painful oral ulcers associated with chemotherapy. Francis G. LeVeque, Jaroslaw Parzuchowski, Giorgia Farinacci, Journal of Clinical Oncology	1992	42
A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy Rajesh V. Lalla, Gary Gordon, Mark Schubert, Supportive Care in Cancer OncologyMedicineOral MedicinePlacebo-controlled TrialHigh-dose Chemotherapy	2011	25

Page 1